The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 5, 2010, Pages 681-688

  Bharucha, A E ^a   Seide, B M ^a   Zinsmeister, A R ^b  

^a MAYO CLINIC   (United States)

^b Department of Health Sciences Research ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE;

ADULT; ANORECTAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FECES INCONTINENCE; FEMALE; HUMAN; OPEN STUDY; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; SYMPTOM; TREATMENT DURATION; URGE INCONTINENCE;

CLONIDINE; DEFECATION; FECAL INCONTINENCE; FEMALE; HUMANS; MIDDLE AGED; SENSATION; SEVERITY OF ILLNESS INDEX; SYMPATHOLYTICS; TREATMENT OUTCOME;

EID: 77955162434     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04391.x     Document Type: Article

References (33)

1. Bharucha AE, Zinsmeister AR, Locke GR, et al. Prevalence and burden of fecal incontinence: a population based study in women. Gastroenterology 2005 129 : 42 9.
2. Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman DA, Whitehead W. Randomized controlled trial shows biofeedback to be superior to alternative treatments for fecal incontinence. Dis Colon Rectum 2009 52 : 1730 1737.
3. Read M, Read NW, Barber DC, Duthie HL. Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci 1982 27 : 807 814.
4. Sun WM, Read NW, Verlinden M. Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scand J Gastroenterol 1997 32 : 34 8.
5. Santoro GA, Eitan BZ, Pryde A, Bartolo DC. Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum 2000 43 : 1676 1681.
6. Cheung O, Wald A. Review article: the management of pelvic floor disorders. Aliment Pharmacol Ther 2004 19 : 481 495.
7. Bharucha AE, Fletcher JG, Harper CM, et al. Relationship between symptoms and disordered continence mechanisms in women with idiopathic fecal incontinence. Gut 2005 54 : 546 555.
8. Andrews C, Bharucha AE, Camilleri M, et al. Rectal sensorimotor dysfunction in women with fecal incontinence. Am J Physiol Gastrointest Liver Physiol 2007 292 : G282 9.
9. Siproudhis L, El Abkari M, El Alaoui M, Juguet F, Bretagne JF. Low rectal volumes in patients suffering from fecal incontinence: what does it mean? Aliment Pharmacol Ther 2005 22 : 989 996.
10. Deutekom M, Dobben AC, Terra MP, et al. Clinical presentation of fecal incontinence and anorectal function: what is the relationship? Am J Gastroenterol 2007 102 : 351 361.
11. Tack JF, Wood JD. Actions of noradrenaline on myenteric neurons in the guinea pig gastric antrum. J Auton Nerv Syst 1992 41 : 67 77.
12. Unnerstall JR, Kopajtic TA, Kuhar MJ. Distribution of alpha 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res 1984 319 : 69 101.
13. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol 1997 273 (Pt 1 G997 1006.
14. Malcolm A, Camilleri M, Kost L, Burton D, Fett S, Zinsmeister A. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Aliment Pharmacol Ther 2000 14 : 783 793.
15. Camilleri M, Kim D-Y, McKinzie S, et al. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2003 1 : 111 121. (Pubitemid 37248082)
16. MacGregor TR, Matzek KM, Keirns JJ, van Wayjen RG, van den Ende A, van Tol RG. Pharmacokinetics of transdermally delivered clonidine. Clin Pharmacol Ther 1985 38 : 278 284.
17. Fujimura A, Ebihara A, Ohashi K, et al. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects. J Clin Pharmacol 1994 34 : 260 265.
18. Bharucha AE, Locke GR, Seide B, Zinsmeister AR. A new questionnaire for constipation and fecal incontinence. Aliment Pharmacol Ther 2004 20 : 355 364.
19. Bharucha AE, Zinsmeister AR, Locke GR, Schleck C, McKeon K, Melton LJ. Symptoms and quality of life in community women with fecal incontinence. Clin Gastroenterol Hepatol 2006 4 : 1004 1009.
20. Heaton KW, O'Donnell LJ. An office guide to whole-gut transit time. Patients' recollection of their stool form. J Clin Gastroenterol 1994 19 : 28 30.
21. Rockwood TH, Church JM, Fleshman JW, et al. Fecal incontinence quality of life scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 2000 43 : 9 16, discussion 16-7.
22. Bharucha AE, Seide B, Fox JC, Zinsmeister AR. Day-to-day reproducibility of anorectal sensorimotor assessments in healthy subjects. Neurogastroenterol Motil 2004 16 : 241 250.
23. Law NM, Bharucha AE, Undale AS, Zinsmeister AR. Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans. Am J Physiol Gastrointest Liver Physiol 2001 281 : G1228 37.
24. Ford MJ, Camilleri M, Wiste JA, Hanson RB. Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut 1995 37 : 264 269.
25. Bharucha A. Fecal incontinence. Gastroenterology 2003 124 : 1672 1685.
26. Scarlett Y. Medical management of fecal incontinence. Gastroenterology 2004 126 (Suppl. 1 S55 63.
27. Viramontes BE, Malcolm A, Camilleri M, et al. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol 2001 281 : G1468 76.
28. Naliboff BD, Berman S, Suyenobu B, et al. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology 2006 131 : 352 365.
29. Bharucha AE, Hubmayr RD, Ferber IJ, Zinsmeister AR. Viscoelastic properties of the human colon. Am J Physiol Gastrointest Liver Physiol 2001 281 : G459 66.
30. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol 1998 274 (Pt 1 G584 90.
31. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993 36 : 77 97.
32. Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum 1999 42 : 1525 1532.
33. Murphy M, Carmichael AJ. Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management. Am J Clin Dermatol 2000 1 : 361 368.